Chiron Sues Corus Pharma For Stealing Trade Secrets
Biotech company Chiron has sued Seattle startup Corus Pharma, which is preparing to go public, for allegedly misappropriating trade secrets underpinning the development of an inhalable drug for cystic fibrosis....To view the full article, register now.
Already a subscriber? Click here to view full article